AxoGen, Inc.

AxoGen (AXGN) is a global leader in innovative surgical solutions for peripheral nerve injuries. AxoGen’s portfolio of products includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments and Avive® Soft Tissue Membrane, a minimally processed human umbilical cord membrane that may be used as a soft tissue covering to modulate inflammation.

Bank Name AxoGen, Inc.
Stock Exchange NASDAQ
Symbol AXGN
Sector Healthcare
Industry Biotechnology: Electromedical
Country United States
World Region America
Chairman Ms. Karen Zaderej
CEO Ms. Karen Zaderej
Employees 184
Website www.axogeninc.com
Registered Year

UpdateContent
UpdateContent
UpdateContent